Skip to main content
HairCited

Low-Level-Lasertherapie für Androgenetische Alopezie

A

Basierend auf 58 Studien (7 meta-analyses, 8 RCTs) mit 11,100 Teilnehmern insgesamt. 49/58 Studien zeigen positive Effekte.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dlow\u002Dlevel\u002Dlaser\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

Low-level laser therapy has strong, well-established evidence for supporting hair growth in androgenetic alopecia, backed by multiple meta-analyses and randomized controlled trials.

  • 49 out of 58 studies show positive effects, supported by 7 meta-analyses and 8 RCTs
  • Stimulates hair follicles through photobiomodulation at specific light wavelengths
  • Included in clinical guidelines as an evidence-based option for pattern hair loss
  • Available as at-home devices (caps, combs, helmets) and clinical in-office systems

Key Study Findings

Review
A Canadian Consensus on Androgenetic Alopecia: Approach and Management.
Dose: None vs.: Placebo Wirkung: None None
review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs.: Placebo Wirkung: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
other n=723
Consensus Recommendations for the Management of Androgenetic Alopecia in Egypt: A Modified Delphi Study.
Dose: None vs.: Placebo Wirkung: 27 consensus statements established across 7 areas: diagnosis, minoxidil, antiandrogens, LLLT, adjuv None
systematic review
Full-Spectrum phototherapy in hair loss management: a systematic review of wavelength-dependent mechanisms, clinical efficacy, and …
Dose: Full-spectrum phototherapy: UVB/UVA, red light, near-infrared (short and long wavelength), mid-infra vs.: Placebo Wirkung: UVB/UVA induces T-cell apoptosis (restoring immune privilege in AA); red light activates mitochondri None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs.: Placebo Wirkung: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
randomized controlled trial n=9 12.5 weeks Single-blind
Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on …
Dose: Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil vs.: Placebo Wirkung: Both groups improved QoL and hair density; PBMt + MIN showed significantly greater reduction in telo None

Key Statistics

60

Studien

11100

Teilnehmer

Positive

A

Bewertung

Referenced Papers

Journal of cutaneous … 2025 2 Zitierungen
Lasers in medical … 2025 1 Zitierungen
International journal of … 2024 39 Zitierungen
Journal of clinical … 2024 10 Zitierungen
Facial plastic surgery … 2024 8 Zitierungen
Revue medicale suisse 2024 2 Zitierungen
Clinical, cosmetic and … 2023 58 Zitierungen
American journal of … 2023 41 Zitierungen
Clinics in plastic … 2023 1 Zitierungen
Dermatology and therapy 2022 43 Zitierungen
Journal of cutaneous … 2021 44 Zitierungen
Actas dermo-sifiliograficas 2021 3 Zitierungen
Expert opinion on … 2020 147 Zitierungen
Dermatologic therapy 2020 48 Zitierungen
Acta dermatovenerologica Alpina, … 2019 7 Zitierungen
Lasers in medical … 2018 75 Zitierungen
Lasers in surgery … 2017 71 Zitierungen
Actas dermo-sifiliograficas 2017 17 Zitierungen
The Cochrane database … 2016 18 Zitierungen
Lasers in surgery … 2014 243 Zitierungen
Facial plastic surgery … 2013 16 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

hairloss:
8-15 minutes, 3x/week

Obergrenze: Not applicable

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
None -- Neutral 723
Full-spectrum phototherapy: UVB/UVA, red light, near-infrared (short and long wavelength), mid-infra -- Positive --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil 12.5 weeks Positive 9
Low-level laser therapy (LLLT) combined with topical minoxidil vs topical minoxidil alone -- Positive --
None -- Positive --

Beste Einnahmezeit: Use device for recommended duration 3 times per week on non-consecutive days

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Mild scalp warmth or tingling
  • Headache (uncommon)
  • Initial shedding phase (rare)
  • Dry scalp

Bekannte Wechselwirkungen

  • Photosensitizing medications (tetracyclines, fluoroquinolones) may increase scalp sensitivity
  • No significant interactions with oral hair loss medications

Tolerierbare Höchstaufnahmemenge: Not applicable

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Low-Level-Lasertherapie help with Androgenetische Alopezie?
Based on 60 studies with 11,100 participants, there is strong evidence from multiple clinical trials that Low-Level-Lasertherapie may support Androgenetische Alopezie management. Our evidence grade is A (Strong Evidence).
How much Low-Level-Lasertherapie should I take for Androgenetische Alopezie?
Studies have used various dosages. A commonly studied range is 8-15 minutes, 3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Low-Level-Lasertherapie?
Reported side effects may include Mild scalp warmth or tingling, Headache (uncommon), Initial shedding phase (rare), Dry scalp. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Low-Level-Lasertherapie and Androgenetische Alopezie?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 60 peer-reviewed studies with 11,100 total participants. The overall direction of effect is positive.

Related Evidence

Low-Level-Lasertherapie für andere Beschwerden

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.